Skip to main content
Livermore
Livermore
ZHEN

Alps Advisors Inc

SEC CIK
0001376113
Latest filing
Jul 29, 2026

KRYS holding history

Krystal Biotech, Inc. in every 13F filed by Alps Advisors Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KRYS overviewAll 13F holders of KRYSFull Q2 2026 holdings

Shares (Q2 2026)
2,035
Value
$756.3K
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of KRYS by Alps Advisors Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,035$756.3K<0.1%+35+1.8%AddedHolders
Q1 20262,000$516.6K<0.1%+2,000NewHolders
Q4 20250$00.0%−13,367−100.0%Sold outHolders
Q3 202513,367$2.36M<0.1%−4,095−23.5%ReducedHolders
Q2 202517,462$2.40M<0.1%+15,542+809.5%AddedHolders
Q1 20251,920$346.2K<0.1%+1,920NewHolders
Q4 20240$00.0%−22,372−100.0%Sold outHolders
Q3 202422,372$4.07M<0.1%+102+0.5%AddedHolders
Q2 202422,270$4.09M<0.1%+22,270NewHolders
Q4 20230$00.0%−20,620−100.0%Sold outHolders
Q3 202320,620$2.39M<0.1%+384+1.9%AddedHolders
Q2 202320,236$2.38M<0.1%+3,259+19.2%AddedHolders
Q1 202316,977$1.36M<0.1%−467−2.7%ReducedHolders
Q4 202217,444$1.38M<0.1%+3,403+24.2%AddedHolders
Q3 202214,041$979.0K<0.1%−1,170−7.7%ReducedHolders
Q2 202215,211$999.0K<0.1%−10,702−41.3%ReducedHolders
Q1 202225,913$1.72M<0.1%−2,906−10.1%ReducedHolders
Q4 202128,819$2.02M<0.1%+1,606+5.9%AddedHolders
Q3 202127,213$1.42M<0.1%−2,028−6.9%ReducedHolders
Q2 202129,241$1.99M<0.1%−6,413−18.0%ReducedHolders
Q1 202135,654$2.75M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.